Rare lephants
Screener

PRELUDE THERAPEUTICS INC

PRLD ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SC 13G/A Jan 10, 2024
4 Jan 8, 2024 PRIMARY DOCUMENT
SC 13D/A Dec 13, 2023 SC 13D/A
4 Dec 13, 2023 FORM 4 SUBMISSION
8-K Dec 11, 2023 8-K
SC 13G Nov 13, 2023 SCHEDULE 13G
10-Q Nov 1, 2023 10-Q
8-K Nov 1, 2023 8-K
4 Oct 6, 2023 PRIMARY DOCUMENT
10-Q Aug 3, 2023 10-Q
8-K Aug 3, 2023 8-K
4 Jul 6, 2023 FORM 4 SUBMISSION
4 Jun 21, 2023 FORM 4 SUBMISSION
4 Jun 21, 2023 FORM 4 SUBMISSION
4 Jun 21, 2023 FORM 4 SUBMISSION
4 Jun 21, 2023 FORM 4 SUBMISSION
4 Jun 21, 2023 FORM 4 SUBMISSION
4 Jun 21, 2023 FORM 4 SUBMISSION
8-K Jun 21, 2023 8-K
8-K Jun 1, 2023 8-K
4 May 26, 2023 PRIMARY DOCUMENT
4 May 25, 2023 PRIMARY DOCUMENT
4 May 25, 2023 PRIMARY DOCUMENT
4 May 25, 2023 PRIMARY DOCUMENT
4 May 24, 2023
← Newer Page 7 of 16 · 389 filings Older →